Navigation Links
ULURU Inc. Reports Second Quarter 2012 Financial Results
Date:8/15/2012

ADDISON, Texas, Aug. 15, 2012 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the quarter ended June 30, 2012 and provided a review of its operating activities.

During the past ninety days, the Company has achieved numerous important milestones including:

  • Convertible debt financing
  • Shipment of Altrazeal® to Australia
  • Oral presentation of Altrazeal® at the major European wound care conference in Vienna
  • Production of Altrazeal® for the veterinary market
  • Extensive pre-marketing activities in Australia including generating important clinical experience data
  • Advancement of strategic alliance discussions
  • Based upon the progress made over the first six months of 2012, we are on target to achieve our stated objectives, which include:

  • Launch of Altrazeal® in the veterinary market
  • Launch of Altrazeal® in 5 markets
  • Completion of additional important strategic alliance
  • Commenting on the commercial activities, Kerry P. Gray, President and CEO, stated, "The progress that has been made in the first six months is very exciting. The advancements that are being made in Europe and Australia, which is supported by additional very positive clinical experience, is positioning the Company for rapidly accelerating growth. The response from the wound management community continues to be very enthusiastic which should enable rapid market penetration in Australia and Europe.  The recognition of the potential clinical and economic benefits of Altrazeal® are the driving forces that are accelerating the interest and momentum behind Altrazeal®.  With the introduction of the 0.75 gram blister pack of Altrazeal®, which is currently in the production cycle, our second half revenues will significantly increase."

    '/>"/>
    SOURCE ULURU Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. ULURU Inc. Announces Completion Of $2.2mil Convertible Debt Offering
    2. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    3. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    4. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    5. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    6. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    7. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    8. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    9. Luminex Corporation Reports First Quarter 2012 Results
    10. Hospira Reports First-Quarter 2012 Results
    11. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
    (Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
    (Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
    Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
    (Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
    (Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
    (Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
    (Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
    (Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
    Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
    ... new study analyzing the economic implications of the ... that the older (first generation) antipsychotic medication perphenazine// ... the newer (second generation) medications used in the ... still have a role in treating schizophrenia. The ...
    ... into a leading Internet search engine, and you’ll find ... ,The latest National Cleaning Survey from The Soap ... reports of skin infections, like Staphylococcus aureus, in their ... resistant to methicillin, a powerful antibiotic commonly used to ...
    ... has fallen drastically, and the rate of decline has improved ... analysis of data// from the National Long-Term Care Survey (NLTCS). ... Academy of Sciences, has revealed that the severe disability among ... in 1982 to 19 percent in 2004/2005. ,The ...
    ... health agencies with the most effective ways of ... personal communication and proper condom use, for example.// ... needle-exchange and substance-abuse programs because they are not ... effectiveness. ,Researchers at the Centers for ...
    ... KC Steakhouse Family Restaurant at Lloydminister, has tested positive for ... virus and affects the liver and causes fever, fatigue, loss ... a few days later. ,“The risk of transmission ... restaurant is small,” said Brenda Cholin, medical health officer for ...
    ... latest issue of Human Gene Therapy has published the ... therapy to treat erectile dysfunction.// The finding shows that ... since gene therapy is beneficial for months, and hence ... ,Lead author Arnold Melman, M.D., professor ...
    Cached Medicine News:Health News:Older Medication May Be More Cost-Effective for Some Schizophrenia Patients 2Health News:Americans’ Concern for Skin Infections, Flu, Spreads Across the Countr 2Health News:Disability Factor Among Older Americans Shows Improvement 2Health News:Best HIV-Prevention Programs Help People Build Skills 2Health News:Best HIV-Prevention Programs Help People Build Skills 3Health News:Gene Therapy May Be the Solution for Erectile Dysfunction 2
    The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
    This unit is the finest standalone handswitch bipolar unit available....
    ...
    ...
    Medicine Products: